Every patent application that unveils nucleotide and/or amino acid sequences must adhere to international filing standards by including sequence listings. The imminent implementation of ST.26, a new sequence listing standard effective from July 1, 2022, is anticipated to enhance the structural framework for seamless data exchange and validation among patent offices and biological sequence search[…]